Andrey A. Ivashchenko

AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial

Andrey A. Ivashchenko, Kirill Dmitriev, Natalia Vostokova et al. · Clinical Infectious Diseases · 2020 · 258 citations · Full text

May 2020, Russian Ministry, Viral Diagnostics +12

Modeling of Human Cytochrome P450-Mediated Drug Metabolism Using Unsupervised Machine Learning Approach

Konstantin V. Balakin, Yuri Nikolsky, Eugene Kirillov et al. · Journal of Medicinal Chemistry · 2003 · 87 citations

Engineering, Machine Learning Approach, Metabolic Model +17

Property-Based Design of GPCR-Targeted Library

Konstantin V. Balakin, Sergey E. Tkachenko, Stanley A. Lang et al. · Journal of Chemical Information and Computer Sciences · 2002 · 72 citations

Drug Target, Engineering, Computer Architecture +23

In Silico Estimation of DMSO Solubility of Organic Compounds for Bioscreening

Konstantin V. Balakin, Yan A. Ivanenkov, A. V. Skorenko et al. · SLAS DISCOVERY · 2004 · 59 citations · Full text

Comprehensive Computational Assessment of ADME Properties Using Mapping Techniques

Konstantin V. Balakin, Yan A. Ivanenkov, Nikolay Savchuk et al. · Current Drug Discovery Technologies · 2005 · 48 citations

Biophysical Modeling, Drug Target, Engineering +19